Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Eur J Clin Microbiol Infect Dis ; 40(4): 841-848, 2021 Apr.
Article in English | MEDLINE | ID: covidwho-893288

ABSTRACT

Coronavirus disease 2019 (COVID-19) with the infection of SARS-CoV-2 has become a serious pandemic worldwide. However, only few studies focused on risk factors of prolonged SARS-CoV-2 RNA detection among patients with COVID-19. We included 206 adult patients with laboratory-confirmed COVID-19 from two hospitals between 23 Jan and 1 April 2020. Least absolute shrinkage and selection operator (LASSO) analysis was used to screen out independent risk factors of SARS-CoV-2 RNA detection. By multivariate binomial logistic regression analysis and Cox regression analysis, we further determined the associations between SARS-CoV-2 RNA detection and potential risk factors. All patients had two negative SARS-CoV-2 tests with 33 days of median duration of SARS-CoV-2 RNA detection (interquartile range: 25.2-39 days). LASSO and binomial logistic regression analyses suggested that delayed hospital admission (adjusted OR = 3.70, 95% CI: 1.82-7.50), hypokalemia, and subpleural lesion (adjusted OR = 4.32, 95% CI: 1.10-16.97) were associated with prolonged SARS-CoV-2 RNA detection. By LASSO and multivariate Cox regression analyses, we observed that delayed hospital admission, subpleural lesion, and high-dose corticosteroid use were independent risk factors of prolonged SARS-CoV-2 RNA detection. Early hospital admission shortened 5.73 days of mean duration of SARS-CoV-2 RNA detection than delayed hospital admission after adjusting confounding factors. Our study demonstrated that delayed hospital admission and subpleural lesion were associated with prolonged SARS-CoV-2 RNA detection among patients with COVID-19. The use of high-dose corticosteroids should be interpreted with extreme caution in treating COVID-19.


Subject(s)
COVID-19/therapy , Glucocorticoids/administration & dosage , Hospitalization/statistics & numerical data , RNA, Viral/isolation & purification , Virus Shedding , Adolescent , Adult , Aged , Aged, 80 and over , Antiviral Agents/therapeutic use , Female , Humans , Logistic Models , Male , Middle Aged , Noninvasive Ventilation , Oxygen Inhalation Therapy , Proportional Hazards Models , Respiration, Artificial , Risk Factors , SARS-CoV-2 , Thymosin/therapeutic use , Time Factors , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL